Click for best price
Ophthalmic Therapeutic Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 16710 million
|
Forecast Market size by 2029 |
US$ 23470 million
|
| Growth Rate |
CAGR of 5.0% |
Number of Pages |
69 Pages |
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Therapeutic Drugs. This report contains market size and forecasts of Ophthalmic Therapeutic Drugs in global, including the following market information:
Global Ophthalmic Therapeutic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Ophthalmic Therapeutic Drugs market was valued at US$ 16710 million in 2022 and is projected to reach US$ 23470 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Anti-inflammatory Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Therapeutic Drugs include Bayer, Pfizer, Novartis, ALLERGAN, Aerie Pharmaceuticals, Bausch Health, Genentech, Regeneron Pharmaceuticals and Takeda, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ophthalmic Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Therapeutic Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Ophthalmic Therapeutic Drugs Market Segment Percentages, by Type, 2022 (%)
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
Global Ophthalmic Therapeutic Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Ophthalmic Therapeutic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Global Ophthalmic Therapeutic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Ophthalmic Therapeutic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Therapeutic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ophthalmic Therapeutic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Bausch Health
Genentech
Regeneron Pharmaceuticals
Takeda
Santen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Therapeutic Drugs, market overview.
Chapter 2: Global Ophthalmic Therapeutic Drugs market size in revenue.
Chapter 3: Detailed analysis of Ophthalmic Therapeutic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Therapeutic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ophthalmic Therapeutic Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 16710 million
|
| Forecast Market size by 2029 |
US$ 23470 million
|
| Growth Rate |
CAGR of 5.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Therapeutic Drugs Overall Market Size
2.1 Global Ophthalmic Therapeutic Drugs Market Size: 2022 VS 2029
2.2 Global Ophthalmic Therapeutic Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ophthalmic Therapeutic Drugs Players in Global Market
3.2 Top Global Ophthalmic Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Ophthalmic Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Ophthalmic Therapeutic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ophthalmic Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ophthalmic Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Ophthalmic Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Ophthalmic Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ophthalmic Therapeutic Drugs Market Size Markets, 2022 & 2029
4.1.2 Anti-inflammatory Drugs
4.1.3 Anti-infective Drugs
4.1.4 Anti-glaucoma Drugs
4.1.5 Anti-allergy Drugs
4.1.6 Anti-VEGF Agents
4.1.7 Others
4.2 By Type - Global Ophthalmic Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Therapeutic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Ophthalmic Therapeutic Drugs Revenue, 2024-2029
4.2.3 By Type - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Therapeutic Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Independent Pharmacies & Drug Stores
5.2 By Application - Global Ophthalmic Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Therapeutic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Ophthalmic Therapeutic Drugs Revenue, 2024-2029
5.2.3 By Application - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Ophthalmic Therapeutic Drugs Market Size, 2022 & 2029
6.2 By Region - Global Ophthalmic Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Therapeutic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Ophthalmic Therapeutic Drugs Revenue, 2024-2029
6.2.3 By Region - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Ophthalmic Therapeutic Drugs Revenue, 2018-2029
6.3.2 US Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.3.3 Canada Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.3.4 Mexico Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Ophthalmic Therapeutic Drugs Revenue, 2018-2029
6.4.2 Germany Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.4.3 France Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.4.4 U.K. Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.4.5 Italy Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.4.6 Russia Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.4.8 Benelux Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Ophthalmic Therapeutic Drugs Revenue, 2018-2029
6.5.2 China Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.5.3 Japan Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.5.4 South Korea Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.5.6 India Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Ophthalmic Therapeutic Drugs Revenue, 2018-2029
6.6.2 Brazil Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.6.3 Argentina Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue, 2018-2029
6.7.2 Turkey Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.7.3 Israel Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Ophthalmic Therapeutic Drugs Market Size, 2018-2029
6.7.5 UAE Ophthalmic Therapeutic Drugs Market Size, 2018-2029
7 Ophthalmic Therapeutic Drugs Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Ophthalmic Therapeutic Drugs Major Product Offerings
7.1.4 Bayer Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Ophthalmic Therapeutic Drugs Major Product Offerings
7.2.4 Pfizer Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Ophthalmic Therapeutic Drugs Major Product Offerings
7.3.4 Novartis Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 ALLERGAN
7.4.1 ALLERGAN Company Summary
7.4.2 ALLERGAN Business Overview
7.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Major Product Offerings
7.4.4 ALLERGAN Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.4.5 ALLERGAN Key News & Latest Developments
7.5 Aerie Pharmaceuticals
7.5.1 Aerie Pharmaceuticals Company Summary
7.5.2 Aerie Pharmaceuticals Business Overview
7.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Major Product Offerings
7.5.4 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.5.5 Aerie Pharmaceuticals Key News & Latest Developments
7.6 Bausch Health
7.6.1 Bausch Health Company Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Ophthalmic Therapeutic Drugs Major Product Offerings
7.6.4 Bausch Health Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.6.5 Bausch Health Key News & Latest Developments
7.7 Genentech
7.7.1 Genentech Company Summary
7.7.2 Genentech Business Overview
7.7.3 Genentech Ophthalmic Therapeutic Drugs Major Product Offerings
7.7.4 Genentech Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.7.5 Genentech Key News & Latest Developments
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Company Summary
7.8.2 Regeneron Pharmaceuticals Business Overview
7.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Major Product Offerings
7.8.4 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.8.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Ophthalmic Therapeutic Drugs Major Product Offerings
7.9.4 Takeda Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Company Summary
7.10.2 Santen Pharmaceutical Business Overview
7.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Major Product Offerings
7.10.4 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue in Global Market (2018-2023)
7.10.5 Santen Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ophthalmic Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Ophthalmic Therapeutic Drugs Market Drivers in Global Market
Table 3. Ophthalmic Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Ophthalmic Therapeutic Drugs in Global Market
Table 5. Top Ophthalmic Therapeutic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ophthalmic Therapeutic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ophthalmic Therapeutic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ophthalmic Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Ophthalmic Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ophthalmic Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Ophthalmic Therapeutic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ophthalmic Therapeutic Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Ophthalmic Therapeutic Drugs Product Offerings
Table 32. Bayer Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Ophthalmic Therapeutic Drugs Product Offerings
Table 36. Pfizer Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Ophthalmic Therapeutic Drugs Product Offerings
Table 40. Novartis Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. ALLERGAN Company Summary
Table 43. ALLERGAN Ophthalmic Therapeutic Drugs Product Offerings
Table 44. ALLERGAN Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. ALLERGAN Key News & Latest Developments
Table 46. Aerie Pharmaceuticals Company Summary
Table 47. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product Offerings
Table 48. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Aerie Pharmaceuticals Key News & Latest Developments
Table 50. Bausch Health Company Summary
Table 51. Bausch Health Ophthalmic Therapeutic Drugs Product Offerings
Table 52. Bausch Health Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Bausch Health Key News & Latest Developments
Table 54. Genentech Company Summary
Table 55. Genentech Ophthalmic Therapeutic Drugs Product Offerings
Table 56. Genentech Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Genentech Key News & Latest Developments
Table 58. Regeneron Pharmaceuticals Company Summary
Table 59. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product Offerings
Table 60. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Regeneron Pharmaceuticals Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Ophthalmic Therapeutic Drugs Product Offerings
Table 64. Takeda Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Key News & Latest Developments
Table 66. Santen Pharmaceutical Company Summary
Table 67. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product Offerings
Table 68. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Santen Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Ophthalmic Therapeutic Drugs Segment by Type in 2022
Figure 2. Ophthalmic Therapeutic Drugs Segment by Application in 2022
Figure 3. Global Ophthalmic Therapeutic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Therapeutic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Ophthalmic Therapeutic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ophthalmic Therapeutic Drugs Revenue in 2022
Figure 8. By Type - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 16. US Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 28. China Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Ophthalmic Therapeutic Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Ophthalmic Therapeutic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ALLERGAN Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bausch Health Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genentech Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
